Vol 91, No 8 (2020)
Review paper
Published online: 2020-08-31
Ophthalmological problems in pregnancy — a review
Abstract
Pregnancy is associated with numerous changes affecting all organs. Ophthalmological changes in pregnant women are most often physiological and resolve spontaneously after delivery. However, the possibility of progression of previously diagnosed ophthalmic diseases or the occurrence of ophthalmological complications in the course of diseases characteristic for pregnancy should always be considered.
Keywords: pregnancyeyeglaucomadiabetic retinopathymyopiapreeclampsiaeclampsiaSheehan’s syndromepapilloedemacentral serous retinopathy
References
- Cantor LB, Safyan E, Liu CC, et al. Brimonidine in the treatment of glaucoma and ocular hypertension. Ther Clin Risk Manag. 2006; 2(4): 337–346.
- Wagenvoort AM, van Vugt JM, Sobotka M, et al. Topical timolol therapy in pregnancy: is it safe for the fetus? Teratology. 1998; 58(6): 258–262, doi: 10.1002/(SICI)1096-9926(199812)58:6<258::AID-TERA7>3.0.CO;2-B.
- Olson R, Bromberg BB, Zimmerman T. Apneic Spells Associated with Timolol Therapy in a Neonate. American Journal of Ophthalmology. 1979; 88(1): 120–122.
- Sharif NA. Synthetic FP-prostaglandin-induced contraction of rat uterus smooth muscle in vitro. Prostaglandins Leukot Essent Fatty Acids. 2008; 78(3): 199–207.
- Alcon Ophthalmics. Azopt Product Monograph. Fort Worth, TX: Alcon Ophthalmics. ; 1998.
- Weaver TE, Scott WJ. Acetazolamide teratogenesis: interaction of maternal metabolic and respiratory acidosis in the induction of ectrodactyly in C57BL/6J mice. Teratology. 1984; 30(2): 195–202.
- Worsham G. Sacrococcygeal Teratoma in a Neonate. JAMA. 1978; 240(3): 251.
- Capino AC, Dannaway DC, Miller JL. Metabolic Acidosis with Ophthalmic Dorzolamide in a Neonate. J Pediatr Pharmacol Ther. 2016; 21(3): 256–259.
- Landauer W. The teratogenic activity of pilocarpine, pilocarpidine and their isomers, with special reference to the importance of steric configuration. Journal of Experimental Zoology. 1956; 132(1): 39–50.
- Kuwagata M, Takashima H, Nagao T. A comparison of the in vivo and in vitro response of rat embryos to 5-fluorouracil. J Vet Med Sci. 1998; 60(1): 93–99.
- Shepard TH, Lemire RJ. Catalog of Teratogenic Agents, 2nd edn. Baltimore, MD: Johns Hopkins University Press, 2004, p. ; 278.
- Avasthi P, Sethi P, Mithal S. Effect of pregnancy and labor on intraocular pressure. Int Surg. 1976; 61(2): 82–84.
- Kearns PP, Dhillon BJ. Angle closure glaucoma precipitated by labour. Acta Ophthalmol (Copenh). 1990; 68(2): 225–226.
- Ophthalmologic and obstetric consensus on indications for caesarean section. Warsaw: Polish Ophthalmological Society. ; 2017.
- Horvat M, Maclean H, Goldberg L, et al. Diabetic retinopathy in pregnancy: a 12-year prospective survey. Br J Ophthalmol. 1980; 64(6): 398–403.
- Chew EY, Mills JL, Metzger BE, et al. Metabolic control and progression of retinopathy. The Diabetes in Early Pregnancy Study. National Institute of Child Health and Human Development Diabetes in Early Pregnancy Study. Diabetes Care. 1995; 18(5): 631–637.
- Lauszus FF, Klebe JG, Bek T, et al. Increased serum IGF-I during pregnancy is associated with progression of diabetic retinopathy. Diabetes. 2003; 52(3): 852–856.
- Rosenn B, Miodovnik M, Kranias G, et al. Progression of diabetic retinopathy in pregnancy: association with hypertension in pregnancy. Am J Obstet Gynecol. 1992; 166(4): 1214–1218.
- Chen HC, Newsom RS, Patel V, et al. Retinal blood flow changes during pregnancy in women with diabetes. Invest Ophthalmol Vis Sci. 1994; 35(8): 3199–3208.
- Tooke JE. Microvascular function in human diabetes. A physiological perspective. Diabetes. 1995; 44(7): 721–726.
- https://www.nice.org.uk/guidance/ng3/resources/diabetes-in-pregnancy-management-from-preconception-to-the-postnatal-period-51038446021.
- Chan WC, Lim LT, Quinn MJ, et al. Management and outcome of sight-threatening diabetic retinopathy in pregnancy. Eye (Lond). 2004; 18(8): 826–832.
- Sinclair SH, Nesler C, Foxman B, et al. Macular edema and pregnancy in insulin-dependent diabetes. Am J Ophthalmol. 1984; 97(2): 154–167.
- Said-Ahmed K, Moustafa G, Fawzy M. Incidence and natural course of symptomatic central serous chorioretinopathy in pregnant women in a maternity hospital in Kuwait. Middle East Afr J Ophthalmol. 2012; 19(3): 273–276.
- Abouammoh MA. Advances in the treatment of central serous chorioretinopathy. Saudi J Ophthalmol. 2015; 29(4): 278–286.
- Fernández-Montero A, Bes-Rastrollo M, Moreno-Montañés J, et al. Effect of pregnancy in myopia progression: the SUN cohort. Eye (Lond). 2017; 31(7): 1085–1092.
- Pizzarello LD. Refractive changes in pregnancy. Graefes Arch Clin Exp Ophthalmol. 2003; 241(6): 484–488.
- Neri A, Grausbord R, Kremer I, et al. The management of labor in high myopic patients. Eur J Obstet Gynecol Reprod Biol. 1985; 19(5): 277–279.
- Schiffman JS, Scherokman B, Tang RA, et al. Evaluation and treatment of papilledema in pregnancy. Compr Ophthalmol Update. 2006; 7(4): 187–202.
- Principles for the protection of patients and volunteers during clinical magnetic resonance diagnostic procedures. Ann N Y Acad Sci. 1992; 649: 372–375.
- Abu Samra K. The eye and visual system in the preeclampsia/eclampsia syndrome: What to expect? Saudi J Ophthalmol. 2013; 27(1): 51–53.
- Krysiak R, Okopień B. [Sheehan's syndrome--a forgotten disease with 100 years' history]. Przegl Lek. 2015; 72(6): 313–320.
- Vaphiades MS, Simmons D, Archer RL, et al. Sheehan syndrome: a splinter of the mind. Surv Ophthalmol. 2003; 48(2): 230–233.
